RARE logo
RARE

Ultragenyx Pharmaceutical Inc

Biotechnology

Ultragenyx Pharmaceutical Inc (RARE) Earnings

Last reported
April 30, 2026
EPS estimate
-$1.50
EPS actual
Revenue est.
$164.2M
Revenue actual